LabCorp, the company that manufactures the Pixel at home stool test, is one of the largest clinical laboratory networks in the world and has 36 primary laboratories all over the United States. The Pixel test is a fecal immunochemical test (FIT), the only stool test approved by the FDA as an accurate and effective screening test for colon cancer. A FIT stool test uses antibodies to detect hidden blood in stool samples, an indication that there may be a polyp or cancerous tumor present in a person’s colon.
A FIT stool test uses antibodies to detect hidden blood in stool samples, an indication that there may be a polyp or cancerous tumor present in a person’s colon.
The Pixel FIT test is one of the more expensive colorectal cancer screening kits on the market but is backed by an accredited scientific company that prides itself in excellence.
The Pixel stool test requires that a person collects a sample of their stool from home and mail the sample to a lab for analysis. There are no restrictions on diet nor medications before taking the test. If you choose to purchase the Pixel FIT test, you have access to PWNHealth, an independent physician partner group that offers consultations if you get a positive result. Your results are provided digitally at the Pixel website and you can download the results and discuss them with your physician. One drawback of this test is there are no directions available on the website on how to take the test.
The Pixel by Labcorp colon cancer screening test kit contains the following:
One kit: $89
Ancrum, S. (2020, August 10). Everylywell review: Pros, cons, and how it works. Retrieved from Farr Institute: https://www.farrinstitute.org/everlywell-review/
Cooper, L. (2016, December 01). At-home colon cancer tests: What you need to know. Retrieved from Consumer Reports: https://www.consumerreports.org/colonoscopy/at-home-colon-cancer-tests/
Pixel Labcorp Writing Staff. (2021). Colorectal Cancer At-Home Test. Retrieved from Pixel Labcorp: https://www.pixel.labcorp.com/at-home-test-kits/colorectal-cancer-home-test
Rabeneck, L., et., al. (2012, March 01). Fecal immunochemical tests compared with guaiac fecal occult blood tests for population-based colorectal cancer screening. Canadian Journal of Gastroenterology, 26(3), 131-147. Retrieved from Europe PMC: http://europepmc.org/article/PMC/3299236